At a glance

ClinicalIndex Comparison Record

Phase 3Completed· 141 enrolled

Drug / intervention

Extended treatmentdrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00459953

NCT00459953Phase 3Completed

Compare CT.gov

Extended Cessation Treatment for Teen Smokers

Stanford University·interventional·Posted Apr 13, 2007·Updated May 30, 2016

In Brief

A Phase 3 clinical trial evaluating Extended treatment for Nicotine Dependence. Completed, enrolled 141 participants across 1 site.

Detailed Summary

This study is designed to test the efficacy of an extended smoking cessation program for teen smokers. We hypothesize that teen smokers randomized to extended treatment will have a higher abstinence rate at 52 week follow-up than teen smokers receiving only open label treatment.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsNicotine Dependence

CountriesUnited States

CollaboratorsNational Institute on Drug Abuse (NIDA), National Cancer Institute (NCI)

Timeline

Phase 3CompletedFinished

200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartSep 2006

First PostedApr 2007

Primary CompletionJun 2011

Study CompletionJul 2011

TodayJul 2026

First PostedApr 13, 2007

Enrollment StartSep 1, 2006

Primary CompletionJun 1, 2011

Study CompletionJul 1, 2011

TodayJul 2, 2026

Enrollment to primary: 4.8 yearsPosted 19.2 years ago

Interventions

Extended treatmentdrug

All participants receive an open label phase treatment that includes nicotine patch and cognitive behavior therapy for a period of 10 weeks. The extended treatment group received an additional 9 sessions of cognitive and behavioral skills training.